Lack of Galectin-3 Prevents Cardiac Fibrosis and Effective Immune Responses in a Murine Model of Trypanosoma cruzi Infection.

BACKGROUND Chagas disease is caused by the protozoan Trypanosoma cruzi, affecting millions of people worldwide. One of the major causes of mortality in the disease is the cardiomyopathy observed in chronic patients, despite the low number of parasites detected in cardiac tissue. Galectin-3, a carbohydrate-binding protein with affinity for β-galactoside-containing glycoconjugates, is upregulated upon infection, and it has been recently involved in the pathophysiology of heart failure. METHODS We investigated the role of galectin-3 in systemic and local responses in a murine model of T. cruzi infection, using knockout animals. Molecular mechanisms underlying galectin-3-dependent inflammatory responses were further assessed in cultured dendritic cells in vitro. RESULTS Mice deficient for galectin-3 have elevated blood parasitemia levels and impaired cytokine production during infection. Remarkably, galectin-3 promotes cellular infiltration in the heart of infected mice and subsequent collagen deposition and cardiac fibrosis. Furthermore, we show that an unbalanced Toll-like receptor expression on antigen-presenting cells may be the cause of the impaired immune response observed in galectin-3-deficient mice in vivo. CONCLUSIONS These results suggest that galectin-3 is strongly involved in Chagas disease, not only in the immune response against T. cruzi, but also in mediating cardiac tissue damage.

[1]  M. Fresno,et al.  Interactions of human galectins with Trypanosoma cruzi: binding profile correlate with genetic clustering of lineages. , 2015, Glycobiology.

[2]  J. Butler,et al.  The Emerging Role of Galectin-3 and ST2 in Heart Failure: Practical Considerations and Pitfalls Using Novel Biomarkers , 2013, Current Heart Failure Reports.

[3]  A. Vargas-Berenguel,et al.  Human galectin-3 selective and high affinity inhibitors. Present state and future perspectives. , 2013, Current medicinal chemistry.

[4]  R. Gazzinelli,et al.  Differential Use of TLR2 and TLR9 in the Regulation of Immune Responses during the Infection with Trypanosoma cruzi , 2013, PloS one.

[5]  Bertram Pitt,et al.  Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis , 2013, Circulation. Heart failure.

[6]  H. Gabius,et al.  Galectin‐3 binds Neisseria meningitidis and increases interaction with phagocytic cells , 2012, Cellular microbiology.

[7]  V. Rodrigues,et al.  In Situ Expression of Regulatory Cytokines by Heart Inflammatory Cells in Chagas' Disease Patients with Heart Failure , 2012, Clinical & developmental immunology.

[8]  Riyao Yang,et al.  Galectins in acute and chronic inflammation , 2012, Annals of the New York Academy of Sciences.

[9]  D. Spray,et al.  Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells , 2011, Cell cycle.

[10]  F. Tzelepis,et al.  Impaired Innate Immunity in Tlr4 −/− Mice but Preserved CD8+ T Cell Responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-Deficient Mice , 2010, PLoS pathogens.

[11]  A. Pshezhetsky,et al.  Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. , 2010, Cellular signalling.

[12]  D. J. Veldhuisen,et al.  Galectin‐3: a novel mediator of heart failure development and progression , 2009, European journal of heart failure.

[13]  N. Henderson,et al.  The regulation of inflammation by galectin‐3 , 2009, Immunological reviews.

[14]  J. Scharfstein,et al.  Proteolytic generation of kinins in tissues infected by Trypanosoma cruzi depends on CXC chemokine secretion by macrophages activated via Toll‐like 2 receptors , 2009, Journal of leukocyte biology.

[15]  M. Nolte,et al.  Inflammatory signals in dendritic cell activation and the induction of adaptive immunity , 2009, Immunological reviews.

[16]  M. Fresno,et al.  Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. , 2008, The Journal of infectious diseases.

[17]  S. Akira,et al.  Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells. , 2008, Molecular immunology.

[18]  O. Carretero,et al.  Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage. , 2008, American journal of physiology. Heart and circulatory physiology.

[19]  Majid Ezzati,et al.  Measuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease Framework , 2007, PLoS neglected tropical diseases.

[20]  S. Sauleda,et al.  Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. , 2007, Acta tropica.

[21]  R. Tarleton Immune system recognition of Trypanosoma cruzi. , 2007, Current opinion in immunology.

[22]  A. Henriques-Pons,et al.  Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection. , 2007, The American journal of pathology.

[23]  J. Correale,et al.  Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death , 2007, Nature Immunology.

[24]  S. Akira,et al.  TLR-Dependent Induction of IFN-β Mediates Host Defense against Trypanosoma cruzi1 , 2006, The Journal of Immunology.

[25]  D. Hsu,et al.  Galectin-3 Induces Death of Candida Species Expressing Specific β-1,2-Linked Mannans1 , 2006, The Journal of Immunology.

[26]  A. Sher,et al.  Cutting Edge: TLR9 and TLR2 Signaling Together Account for MyD88-Dependent Control of Parasitemia in Trypanosoma cruzi Infection1 , 2006, The Journal of Immunology.

[27]  F. Kierszenbaum Where do we stand on the autoimmunity hypothesis of Chagas disease? , 2005, Trends in parasitology.

[28]  C. Petersen,et al.  Toll-Like Receptor 2 Regulates Interleukin-1β-Dependent Cardiomyocyte Hypertrophy Triggered by Trypanosoma cruzi , 2005, Infection and Immunity.

[29]  C. Ropert,et al.  Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi , 2004, Journal of endotoxin research.

[30]  Yigal M. Pinto,et al.  Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction , 2004, Circulation.

[31]  M. Lima,et al.  Human Galectin-3 Promotes Trypanosoma cruzi Adhesion to Human Coronary Artery Smooth Muscle Cells , 2004, Infection and Immunity.

[32]  P. Ricciardi-Castagnoli,et al.  Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. , 2004, Glycobiology.

[33]  G. Rabinovich,et al.  Galectin-3 Mediates IL-4-Induced Survival and Differentiation of B Cells: Functional Cross-Talk and Implications during Trypanosoma cruzi Infection 1 , 2004, The Journal of Immunology.

[34]  G. Caron,et al.  The Trypanosoma cruzi Tc52-Released Protein Induces Human Dendritic Cell Maturation, Signals Via Toll-Like Receptor 2, and Confers Protection Against Lethal Infection1 , 2002, The Journal of Immunology.

[35]  S. Akira,et al.  Glycosylphosphatidylinositol‐anchored mucin‐like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP‐1 production by IFN‐γ‐primed‐macrophages , 2002, Journal of leukocyte biology.

[36]  R. Ribeiro‐dos‐Santos,et al.  The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. , 2001, Anais da Academia Brasileira de Ciencias.

[37]  R. Tarleton Parasite persistence in the aetiology of Chagas disease. , 2001, International journal for parasitology.

[38]  T. Eberlein,et al.  Expression and function of galectin‐3, a β‐galactoside‐binding protein in activated T lymphocytes , 2001, Journal of Leukocyte Biology.

[39]  J. Dennis,et al.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.

[40]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  I. C. Almeida,et al.  Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents , 2000, The EMBO journal.

[42]  F. Villalta,et al.  Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin‐3 , 2000, FEBS letters.

[43]  R. Tarleton,et al.  Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. , 1999, The Journal of infectious diseases.

[44]  S. Reed,et al.  Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells , 1996, Infection and immunity.

[45]  M. Levin,et al.  Humoral autoimmune response in Chagas' disease: Trypanosoma cruzi ribosomal antigens as immunizing agents. , 1993, FEMS immunology and medical microbiology.

[46]  J. F. Fernandes,et al.  Differentiation of Trypanosoma cruzi in culture. , 1967, The Journal of protozoology.

[47]  S. Akira,et al.  TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi. , 2006, Journal of immunology.

[48]  M. Fresno,et al.  Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. , 2005, Current topics in microbiology and immunology.

[49]  M. Fresno,et al.  Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? , 2003, Trends in parasitology.

[50]  T. Eberlein,et al.  Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. , 2001, Journal of leukocyte biology.